Anaesthesia complication rates

Article

Anaesthesia administered by sharp needles carries a greater risk of serious complications than subtenons cannula administration, according to a study published online ahead of print in Eye.

Anaesthesia administered by sharp needles carries a greater risk of serious complications than subtenons cannula administration, according to a study published online ahead of print in Eye.

Rob L. Johnston of Gloucestershire Eye Department, Cheltenham General Hospital, UK and colleagues evaluated the Cataract National Dataset, which contains electronically recorded patient data gathered from 12 UK National Health Service Trusts.

An ophthalmologist administered anaesthetic in 56.7% of the 55 567 operations performed; anaesthetic was administered by an anaesthetist for 42.1% of operations, and by an assistant in 0.3% of the cases (personnel administering anaesthesia in the remaining 0.9% was unrecorded).

Across all Trusts, local anaesthesia was used in 95.5% of cases; topical anaesthesia, 22.3%; topical and intracameral, 4.7%; subtenons, 46.9%; peribulbar, 19.5%; retrobulbar, 0.5%. Minor complications (≥1) associated with sharp needle or subtenons cannula administration occurred in 4.3% of cases, with subtenons administration being 2.3 times more likely than sharp needles to cause minor complications. Serious complications associated with sharp needle or subtenons cannula administration occurred in 0.066% of cases (n=25), with sharp needle administration being 2.5 times more likely than subtenons to cause serious complications.

The team noted that, although subtenons administration of anaesthesia was associated with a greater risk of minor complications, sharp needles were more likely to produce serious complications.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.